C07K 14/70575
Ngf/tnf-superfamily
Official title: {NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154 (NGF C07K14/48, TNF C07K14/525)}
C07K14/70575 (Ngf/tnf-superfamily) appears on 690 US grants and 1,231 published applications in this corpus.
Search patents in C07K- Granted patents
- 690
- Published applications
- 1,231
- Assignees
- 505
- Inventors
- 2,035
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 2 | 0 |
| 1998 | 6 | 0 |
| 1999 | 10 | 0 |
| 2000 | 15 | 0 |
| 2001 | 20 | 2 |
| 2002 | 21 | 45 |
| 2003 | 22 | 65 |
| 2004 | 15 | 43 |
| 2005 | 10 | 42 |
| 2006 | 16 | 36 |
| 2007 | 21 | 32 |
| 2008 | 19 | 25 |
| 2009 | 21 | 38 |
| 2010 | 22 | 31 |
| 2011 | 21 | 34 |
| 2012 | 16 | 28 |
| 2013 | 19 | 31 |
| 2014 | 16 | 25 |
| 2015 | 22 | 41 |
| 2016 | 16 | 32 |
| 2017 | 30 | 39 |
| 2018 | 27 | 65 |
| 2019 | 35 | 71 |
| 2020 | 42 | 90 |
| 2021 | 45 | 86 |
| 2022 | 40 | 79 |
| 2023 | 32 | 64 |
| 2024 | 44 | 69 |
| 2025 | 33 | 78 |
| 2026 | 27 | 40 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- K562 universal antigen presenting cells and uses thereof15 Sep 2026US 12,734,239 B2Board of Regents, The University of Texas System
- TNFR2 agonists with improved stability15 Sep 2026US 12,735,472 B2Universität Stuttgart
- DARIC interleukin receptors21 Jul 2026US 12,686,711 B2Regeneron Pharmaceuticals, Inc.
- Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion7 Jul 2026US 12,673,982 B2Iovance Biotherapeutics, Inc.
- CD154 peptides and methods of reducing inflammation9 Jun 2026US 12,649,775 B2Op-T LLC
- Chimeric polypeptides, extracellular vesicles comprising the same, and uses thereof1 Oct 2026US 2026/0295068 A1Ciloa
- Method for the production of bi-functional cells to treat neoplasia1 Oct 2026US 2026/0297162 A1Eir Biotherapies Srl
- Light-expressing immunoresponsive cells and uses thereof1 Oct 2026US 2026/0297517 A1Memorial Sloan Kettering Cancer Center
- Immunostimulatory antigen binding molecules that specifically bind to bcma24 Sep 2026US 2026/0285998 A1Hoffmann-La Roche Inc.
- CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy24 Sep 2026US 2026/0286300 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Data security system and method for portable device291US 7,313,825 B2Digital Doors, Inc. · 2007
- Data security system and method associated with data mining250US 7,322,047 B2Digital Doors, Inc. · 2008
- CD30 ligand136US 5,480,981 AImmunex Corporation · 1996
- Data security system and method with multiple independent levels of security120US 7,669,051 B2DigitalDoors, Inc. · 2010
- Antibodies that immunospecifically bind BLyS113US 7,138,501 B2Human Genome Sciences, Inc. · 2006